EVM
BPMC
Eaton Vance Management’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $3.39M | Sell |
51,484
-126
| -0.2% | -$8.3K | 0.01% | 886 |
|
|
2022
Q2 | $2.61M | Sell |
51,610
-54,219
| -51% | -$2.74M | ﹤0.01% | 997 |
|
|
2022
Q1 | $6.76M | Sell |
105,829
-157,356
| -60% | -$10.1M | 0.01% | 807 |
|
|
2021
Q4 | $28.2M | Sell |
263,185
-277
| -0.1% | -$29.7K | 0.03% | 405 |
|
|
2021
Q3 | $27.1M | Buy |
263,462
+653
| +0.2% | +$67.1K | 0.04% | 376 |
|
|
2021
Q2 | $23.1M | Sell |
262,809
-21,543
| -8% | -$1.89M | 0.03% | 425 |
|
|
2021
Q1 | $27.6M | Sell |
284,352
-186,138
| -40% | -$18.1M | 0.04% | 374 |
|
|
2020
Q4 | $52.8M | Buy |
470,490
+215,490
| +85% | +$24.2M | 0.08% | 230 |
|
|
2020
Q3 | $23.6M | Sell |
255,000
-266,403
| -51% | -$24.7M | 0.04% | 333 |
|
|
2020
Q2 | $40.7M | Buy |
521,403
+9,106
| +2% | +$710K | 0.08% | 221 |
|
|
2020
Q1 | $30M | Buy |
512,297
+296,931
| +138% | +$17.4M | 0.07% | 232 |
|
|
2019
Q4 | $17.3M | Buy |
215,366
+41,016
| +24% | +$3.29M | 0.03% | 363 |
|
|
2019
Q3 | $12.8M | Buy |
174,350
+81,894
| +89% | +$6.02M | 0.03% | 396 |
|
|
2019
Q2 | $8.72M | Buy |
+92,456
| New | +$8.72M | 0.02% | 460 |
|